• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    GW Pharmaceuticals plc (GWPH)

    -NasdaqGM
    44.20 Up 0.58(1.33%) Feb 11, 4:00PM EST
    ProfileGet Profile for:
    GW Pharmaceuticals plc
    Sovereign House
    Vision Park
    Cambridge, CB24 9BZ
    United Kingdom - Map
    Phone: 44 1223 266 800
    Fax: 44 1223 235 667
    Website: http://www.gwpharm.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:369

    Business Summary 

    GW Pharmaceuticals plc, a biopharmaceutical company, together with its subsidiaries, engages in discovering, developing, and commercializing cannabinoid prescription medicines. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company primarily offers Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain; and Phase 2 trials in other indications, such as neuropathic pain. In addition, the company’s product pipeline includes Epidiolex, a treatment for Dravet syndrome and Lennox-Gastaut syndrome, as well as other product candidates in Phase 1 and 2 clinical development for the treatment of glioma, adult epilepsy, type-2 diabetes, and schizophrenia. It operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on GW Pharmaceuticals plc

    Key Executives 
     PayExercised
    Dr. Geoffrey W. Guy BSc, MB BS, MRCS Eng, LRCP, LMSSA. Dip Pharm Med, 62
    Founder, Exec. Chairman and Chairman of Nominations Committee
    N/AN/A
    Mr. Justin D. Gover BSc, MBA, 45
    Chief Exec. Officer and Exec. Director
    N/AN/A
    Mr. Adam David George BSc, ACA, 46
    Chief Financial Officer, Company Sec. and Exec. Director
    N/AN/A
    Mr. Christopher John Tovey BSc, 51
    Chief Operating Officer and Exec. Director
    N/AN/A
    Dr. Stephen Wright MA, M.D., FRCP (Edin), FFPM., 64
    Chief Medical Officer, R&D Director and Exec. Director
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.